- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
GlaxoSmithKline (GSK) is working on a two-pill HIV regimen that could potentially change the standard of HIV treatment and push it ahead of rival pharmaceutical companies.
London based investment manager warns of further falls in U.K dividends.
Which stocks will be most favored by the corporate-bond purchases?